pharmaphorum

MAY 7, 2021

CRISPR’s deal with Nkarta aims to create genetically engineered NK cells, which are harvested and used to create a bank of “off the shelf” cells that can administered to patients like a drug. Nkarta also gets a license to CRISPR gene editing to an unlimited number of its own NK cell therapy products.

Gene Editing 52

Gene Editing Gene Genetic Engineering DNA 52

The Pharma Data

OCTOBER 26, 2020

PEX TM and MabIgX® technology platforms to rapidly identify rare, potent antibody-producing B-cells from patients who have successfully overcome an infection, and to rapidly manufacture monoclonal antibody (mAbs) for therapeutic treatment of critical infections.

Antibody 52

Antibody Genetic Engineering Development Licensing 52

Roots Analysis

AUGUST 31, 2023

coli bacteria, as well as lambda bacteriophage, can adapt to the alterations in the composition of their nutrient medium. Therefore, although a gene switch may induce programmed cell death in culture cells to mitigate adverse events caused by engineered cell therapies, it could be considered insufficient / dangerous for clinical practice.

Gene 40

Gene Gene Therapy Gene Expression Regulation 40